NCT05188716View on ClinicalTrials.gov

Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

October 13, 2021

Study Completion Date

January 15, 2022

Conditions
Cervical CancerBenign Tumor of Uterus
Trial Locations (1)

515031

Cancer Hospital of Shantou University Medical College, Shantou

All Listed Sponsors
lead

Chuangzhen Chen

OTHER

NCT05188716 - Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer | Biotech Hunter | Biotech Hunter